CYCN Cyclerion Therapeutics, Inc. - Common Stock
$4.12
价格 · 八月 19, 2026
截至...的财报数据 八月 4, 2026
CYCN 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$4.12
市值
—
P/E (TTM)
-1.1
每股收益 (TTM)
$-1.11
营收 (TTM)
$2M
股息收益率
—
ROE
—
负债/权益
—
52周区间
$1 – $8
CYCN 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$2M
2019-12-31
→
2025-12-31
EPS
$-1.11
2021-12-31
→
2025-12-31
自由现金流
—
2019-12-31
→
2022-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CYCN
同行中位数
P/E (TTM)
-1.1
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CYCN
同行中位数
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CYCN
同行中位数
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CYCN
同行中位数
Revenue YoY (营收同比增长)
3.7%
—
Revenue CAGR 3Y (营收3年复合年增长率)
91.1%
—
Revenue CAGR 5Y (营收5年复合年增长率)
-2.0%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CYCN
同行中位数
CYCN 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
7 位分析师
- 强烈买入 2 28.6%
- 买入 4 57.1%
- 持有 1 14.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
1 位分析师 · 2026-08-17
最低
$8.00
最高
$8.00
中位数目标
$8.00
+94.2%
平均目标
$8.00
+94.2%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.37%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2025年12月31日 | $-0.21 | $-0.39 | 0.18% |
| 2025年9月30日 | $-0.30 | — | — |
| 2025年6月30日 | $-0.11 | — | — |
| 2023年9月30日 | $-0.93 | $-0.34 | -0.59% |
| 2022年9月30日 | $-4.80 | $-6.32 | 1.5% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CYCN | — | -1.1 | 3.7% | — | — | — |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| HOWL | $31M | -0.5 | — | — | -183.6% | — |
| KALA | $15M | -0.2 | — | — | -1423.8% | — |
| TPST | $14M | -0.5 | — | — | -319.3% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $0 | $297.0K | $4M | $2M | $5M | |
| R&D Expense | $959.0K | $286.0K | $2M | $6M | $38M | $56M | $95M | |
| SG&A Expense | $6M | $5M | $8M | $13M | $21M | $29M | $34M | |
| Operating Expenses | $7M | $6M | $13M | $19M | $59M | $84M | $130M | |
| Operating Income | $-5M | $-4M | $-13M | $-19M | $-55M | $-81M | $-125M | |
| Other Non-op | $1M | $571.0K | $358.0K | $294.0K | $-16.0K | $588.0K | · | |
| Pretax Income | $-4M | $-3M | $-5M | $-44M | $-52M | $-122M | $-122M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-4M | $-3M | $-5M | $-44M | $-52M | $-78M | $-123M | |
| EPS (Basic) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 | · | · | |
| EPS (Diluted) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 | · | · | |
| Shares (Basic) | 3,181,000 | 2,518,000 | 2,338,000 | 2,173,000 | 39,144,000 | · | · | |
| Shares (Diluted) | 3,181,000 | 2,518,000 | 2,338,000 | 2,173,000 | 39,144,000 | · | · | |
| EBITDA | · | $-4M | $-13M | $-44M | $-55M | · | $-125M |
资产负债表 21
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $8M | $13M | $54M | $54M | $95M | |
| Receivables | $1M | $556.0K | $0 | $96.0K | $100.0K | $0 | · | |
| Prepaid Expense | $384.0K | $421.0K | $442.0K | $805.0K | $928.0K | $816.0K | $2M | |
| Other Current Assets | $11.0K | $16.0K | $11.0K | $537.0K | $468.0K | $3M | $3M | |
| Current Assets | $5M | $4M | $8M | $15M | $55M | $59M | $101M | |
| PP&E (Net) | $0 | $0 | $0 | $0 | $65.0K | $7M | $12M | |
| PP&E (Gross) | · | $126.0K | $126.0K | $2M | $2M | $17M | $33M | |
| Accum. Depreciation | · | $126.0K | $126.0K | $2M | $2M | $10M | $22M | |
| Other Non-current Assets | · | · | $0 | $2M | $2M | $3M | $540.0K | |
| Total Assets | $10M | $10M | $13M | $18M | $59M | $115M | $186M | |
| Accounts Payable | $508.0K | $390.0K | $1M | $3M | $2M | $1M | $3M | |
| Short-term Debt | · | · | · | $4M | $4M | $4M | · | |
| Current Liabilities | $900.0K | $725.0K | $2M | $8M | $11M | $17M | $18M | |
| Capital Leases | · | · | · | · | $0 | $39M | $70M | |
| Total Debt | · | · | · | $4M | $4M | · | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Retained Earnings | $-271M | $-267M | $-264M | $-259M | $-215M | $-163M | $-86M | |
| AOCI | · | $0 | $-12.0K | $-20.0K | $-23.0K | $-27.0K | $-20.0K | |
| Stockholders' Equity | $9M | $9M | $11M | $10M | $48M | $59M | $98M | |
| Liabilities + Equity | $10M | $10M | $13M | $18M | $59M | $115M | $186M | |
| Shares Outstanding | 3,821,236 | 2,545,922 | 2,474,159 | 2,175,936 | 2,170,509 | 34,047,300 | 27,598,133 |
现金流 11
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $65.0K | $472.0K | $2M | $3M | |
| Stock-based Comp | $441.0K | $625.0K | $1M | $6M | $10M | $15M | $20M | |
| Restructuring | · | · | $-565.0K | $-1M | · | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-21M | $-41M | $-37M | $-72M | $-102M | |
| CapEx | · | · | · | $0 | $7.0K | $2M | $7M | |
| Investing Cash Flow | · | $0 | $10M | $0 | $1M | $18.0K | $-7M | |
| Stock Issued | $1M | $0 | $5M | $0 | · | · | · | |
| Net Stock Activity | · | $0 | $5M | · | · | · | · | |
| Financing Cash Flow | $3M | $0 | $5M | $29.0K | $31M | $28M | $212M | |
| Net Change in Cash | $8.0K | $-4M | $-6M | $-41M | $-4M | $-44M | $103M | |
| Free Cash Flow | · | · | · | $-41M | $-37M | · | $-109M |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -181.4% | · | -2730.6% | -1400.2% | · | -2774.3% | |
| Net Margin | · | -152.8% | · | -2712.5% | -1310.2% | · | -2729.3% | |
| Pretax Margin | · | -152.8% | · | -2712.5% | -1310.2% | · | -2715.9% | |
| EBITDA Margin | · | -181.4% | · | -2730.6% | -1400.2% | · | -2774.3% | |
| ROA | · | · | -33.5% | -113.9% | -59.1% | · | -126.9% | |
| ROE | · | · | -43.6% | -326.8% | -98.7% | · | -113.4% | |
| ROIC | · | · | -114.7% | -318.0% | -106.7% | · | -127.9% |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 3.8 | 1.9 | 5.0 | · | 5.5 | |
| Quick Ratio | · | · | 3.6 | 1.8 | 4.9 | · | 5.2 | |
| Debt / Equity | · | · | · | 0.3 | 0.1 | · | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | 0.0 | 16.6 | 78.8 | · | · |
增长率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.7% | · | · | -92.5% | 71.7% | · | · | |
| Revenue CAGR 3Y | 91.1% | -20.2% | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $0 | $297.0K | $4M | $2M | $5M | |
| Net Income TTM | $-4M | $-3M | $-5M | $-44M | $-52M | $-78M | $-123M | |
| Market Cap | · | · | $8M | $571M | $1.49B | · | $1.50B | |
| Enterprise Value | · | · | · | $561M | $1.44B | · | · | |
| P/E | -1.1 | -2.7 | -1.5 | -0.6 | -26.1 | · | · | |
| P/S | · | · | · | 1922.4 | 378.8 | · | 333.1 | |
| P/B | · | · | 0.7 | 54.6 | 31.0 | · | 15.4 | |
| P / Tangible Book | 0.5 | 0.9 | 0.7 | 54.6 | 31.0 | 35.0 | · | |
| P / Cash Flow | · | · | -0.4 | -14.1 | -40.9 | · | -14.7 | |
| P / FCF | · | · | · | -14.1 | -40.9 | · | -13.8 | |
| EV / EBITDA | · | · | · | -12.6 | -26.1 | · | · | |
| EV / FCF | · | · | · | -13.8 | -39.5 | · | · | |
| EV / Revenue | · | · | · | 1889.2 | 366.0 | · | · | |
| Earnings Yield | -87.4% | -37.6% | -67.2% | -154.6% | -3.8% | · | · |
损益表 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1M | $875.0K | $93.0K | $81.0K | $2M | $194.0K | $0 | $0 | $0 | $0 | $0 | $0 | $-720.0K | $0 | |
| R&D Expense | $0 | $730.0K | $519.0K | $348.0K | $56.0K | $36.0K | $56.0K | $81.0K | $105.0K | $44.0K | $24.0K | $580.0K | $339.0K | $572.0K | $-15M | $1M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | |
| Operating Expenses | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $6M | $2M | $3M | $-13M | $5M | |
| Operating Income | $-2M | $-3M | $-838.0K | $-1M | $-2M | $-1M | $502.0K | $-1M | $-1M | $-2M | $-2M | $-6M | $-2M | $-3M | $12M | $-5M | |
| Other Non-op | $16.0K | $32.0K | $39.0K | $30.0K | $1M | $28.0K | $28.0K | $405.0K | $62.0K | $76.0K | $101.0K | $107.0K | $62.0K | $88.0K | $132.0K | $111.0K | |
| Net Income | $-2M | $-3M | $-799.0K | $-976.0K | $-324.0K | $-1M | $530.0K | $-723.0K | $-1M | $-2M | $-2M | $8M | $-4M | $-7M | $-7M | $-10M | |
| EPS (Basic) | $-0.41 | $-0.76 | $-0.14 | $-0.30 | $-0.11 | $-0.56 | $0.23 | $-0.29 | $-0.53 | $-0.62 | $-0.32 | $3.10 | $-1.83 | $-3.20 | $-8.99 | $-4.83 | |
| EPS (Diluted) | $-0.41 | $-0.76 | $-0.14 | $-0.30 | $-0.11 | $-0.56 | $0.23 | $-0.29 | $-0.53 | $-0.62 | $0.06 | $2.72 | $-1.83 | $-3.20 | $-8.99 | $-4.83 | |
| Shares (Basic) | 4,251,000 | 4,205,000 | -5,671,000 | 3,225,000 | 3,071,000 | 2,556,000 | -5,012,000 | 2,526,000 | 2,510,000 | 2,494,000 | -4,555,000 | 2,435,000 | 2,282,000 | 2,176,000 | -2,217,425 | 2,174,000 | |
| Shares (Diluted) | 4,251,000 | 4,205,000 | -5,671,000 | 3,225,000 | 3,071,000 | 2,556,000 | -5,012,000 | 2,526,000 | 2,510,000 | 2,494,000 | -4,906,000 | 2,786,000 | 2,282,000 | 2,176,000 | -2,217,425 | 2,174,000 | |
| EBITDA | $-2M | $-3M | · | $-1M | $-2M | $-1M | · | $-1M | $-1M | $-2M | · | $-6M | $-4M | $-7M | · | $-11M |
资产负债表 18
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $3M | $3M | $5M | $3M | $4M | $3M | $3M | $5M | $6M | $8M | $9M | $6M | $7M | $13M | $20M | |
| Receivables | $0 | $0 | $1M | $100.0K | $525.0K | $581.0K | $556.0K | $44.0K | · | · | $0 | $0 | $0 | $96.0K | $96.0K | $227.0K | |
| Prepaid Expense | $112.0K | $255.0K | $384.0K | $386.0K | $462.0K | $256.0K | $421.0K | $621.0K | $116.0K | $308.0K | $442.0K | $726.0K | $1M | $567.0K | $805.0K | $536.0K | |
| Other Current Assets | $11.0K | $11.0K | $11.0K | $11.0K | $27.0K | $21.0K | $16.0K | $11.0K | $11.0K | $10.0K | $11.0K | $30.0K | $428.0K | $503.0K | $537.0K | $488.0K | |
| Current Assets | $2M | $3M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | $6M | $8M | $10M | $7M | $8M | $15M | $22M | |
| PP&E (Net) | $66.0K | $66.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| PP&E (Gross) | · | · | · | $126.0K | $126.0K | $126.0K | · | $126.0K | $126.0K | $126.0K | $126.0K | $126.0K | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | · | · | · | $126.0K | $126.0K | $126.0K | · | $126.0K | $126.0K | $126.0K | $126.0K | $126.0K | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $2M | $2M | $2M | |
| Total Assets | $7M | $9M | $10M | $10M | $9M | $10M | $10M | $9M | $10M | $11M | $13M | $15M | $10M | $11M | $18M | $25M | |
| Accounts Payable | $2M | $457.0K | $508.0K | $480.0K | $462.0K | $483.0K | $390.0K | $304.0K | $651.0K | $741.0K | $1M | $814.0K | $2M | $4M | $3M | $2M | |
| Current Liabilities | $2M | $2M | $900.0K | $877.0K | $800.0K | $1M | $725.0K | $700.0K | $1M | $1M | $2M | $2M | $5M | $8M | $8M | $9M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-276M | $-274M | $-271M | $-270M | $-269M | $-269M | $-267M | $-268M | $-267M | $-266M | $-264M | $-263M | $-270M | $-266M | $-259M | $-252M | |
| AOCI | · | · | · | · | · | · | · | $0 | $0 | $-16.0K | $-12.0K | $-18.0K | $-16.0K | $-19.0K | $-20.0K | $-28.0K | |
| Stockholders' Equity | $5M | $7M | $9M | $10M | $9M | $9M | $9M | $8M | $9M | $10M | $11M | $13M | $5M | $4M | $10M | $17M | |
| Liabilities + Equity | $7M | $9M | $10M | $10M | $9M | $10M | $10M | $9M | $10M | $11M | $13M | $15M | $10M | $11M | $18M | $25M | |
| Shares Outstanding | 4,256,284 | 4,241,260 | 3,821,236 | 3,695,158 | 3,075,968 | 3,060,944 | 2,545,922 | 2,530,898 | 2,515,874 | 2,499,601 | 2,474,159 | 2,445,096 | 2,407,796 | 43,524,894 | 2,175,936 | 43,494,184 |
现金流 11
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Stock-based Comp | $51.0K | $58.0K | $95.0K | $118.0K | $114.0K | $114.0K | $122.0K | $138.0K | $184.0K | $181.0K | $103.0K | $159.0K | $379.0K | $426.0K | $1M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $0 | $-692.0K | $-127.0K | $0 | · | · | |
| Operating Cash Flow | $-1M | $-1M | $-2M | $-264.0K | $-503.0K | $-968.0K | $360.0K | $-2M | $-1M | $-2M | $-2M | $-7M | $-7M | $-6M | $-7M | $-10M | |
| CapEx | $0 | $66.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Investing Cash Flow | $0 | $-66.0K | · | · | $0 | $0 | · | $0 | · | · | $0 | $10M | · | · | $0 | $0 | |
| Stock Issued | · | · | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $825.0K | $251.0K | $2M | $-130.0K | $1M | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $12.0K | $0 | |
| Net Change in Cash | $-1M | $-417.0K | $-1M | $2M | $-633.0K | $407.0K | $360.0K | $-2M | $-1M | $-2M | $-2M | $3M | $-2M | $-6M | $-7M | $-10M | |
| Free Cash Flow | · | $-1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -115.0% | -1797.9% | -1798.8% | · | -581.4% | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | -111.5% | -348.4% | -1764.2% | · | -372.7% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | -115.0% | -1797.9% | -1798.8% | · | -581.4% | · | · | · | · | · | · | · | · | |
| ROA | -21.5% | -34.6% | · | -10.1% | -3.3% | -13.5% | · | -6.0% | -13.1% | -13.5% | · | 37.6% | -18.5% | -24.0% | · | -22.6% | |
| ROE | -25.7% | -40.8% | · | -11.0% | -3.7% | -15.3% | · | -6.9% | -19.0% | -22.3% | · | 51.5% | -27.4% | -34.0% | · | -28.8% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.8 | · | 5.8 | 5.0 | 4.2 | · | 5.1 | 3.7 | 4.2 | · | 4.2 | 1.4 | 1.1 | · | 2.5 | |
| Quick Ratio | 0.8 | 1.6 | · | 5.3 | 4.4 | 4.0 | · | 4.2 | 3.6 | 4.0 | · | 3.9 | 1.1 | 1.0 | · | 2.4 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 0.0 | · | 12.2 | 0.4 | 0.2 | · | 8.8 | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $368.0K | $275.0K | · | $194.0K | $0 | $0 | · | $0 | $306.0K | $1M | · | $1M | |
| Net Income TTM | $-6M | $-6M | · | $-3M | $-4M | $-5M | · | $4M | $521.0K | $-5M | · | $-14M | $-35M | $-44M | · | $-48M | |
| Market Cap | $14M | $7M | · | $8M | $9M | $8M | · | $7M | $6M | $8M | · | $8M | $10M | $378M | · | $748M | |
| P/E | -2.1 | -0.9 | · | -1.8 | -2.0 | -1.2 | · | 2.0 | -8.8 | -1.1 | · | -0.5 | -0.3 | -0.6 | · | -1.5 | |
| P/S | 13.8 | 6.3 | · | 6.8 | 24.3 | 27.8 | · | 33.8 | · | · | · | · | 32.4 | 371.5 | · | 548.1 | |
| P/B | 2.8 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.6 | 1.9 | 96.3 | · | 45.3 | |
| P / Tangible Book | 2.8 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.6 | 1.9 | 96.3 | · | 45.3 | |
| P / Cash Flow | · | -5.6 | · | · | · | -7.9 | · | · | · | -4.3 | · | · | · | -60.8 | · | · | |
| P / FCF | · | -5.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -46.6% | -111.6% | · | -54.8% | -51.2% | -80.0% | · | 49.4% | -11.3% | -91.6% | · | -208.8% | -388.8% | -166.9% | · | -67.2% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $2M | $2M | $0 | $297.0K | $4M |
| 营业利润率 % | — | -181.4% | — | -2730.6% | -1400.2% |
| 净收入 | $-4M | $-3M | $-5M | $-44M | $-52M |
| 稀释后每股收益 (EPS) | $-1.11 | $-1.21 | $-2.25 | $-20.28 | $-1.32 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | — | — | — | 0.3 | 0.1 |
| 流动比率 | — | — | 3.8 | 1.9 | 5.0 |
| 速动比率 | — | — | 3.6 | 1.8 | 4.9 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | — | — | — | $-41M | $-37M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 24 家申报者 · $10.6M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 11 (+6 与上一季度对比) | 5 (0 与上一季度对比) | 3 (+2 与上一季度对比) | 2 (0 与上一季度对比) | +2.8M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Kalehua Capital Management LLC | $5598077 | 1651350 | 52.72% | 股份 |
| FMR LLC | $1226457 | 361787 | 11.55% | 股份 |
| Balyasny Asset Management L.P. | $1076362 | 317511 | 10.14% | 股份 |
| ADAR1 Capital Management, LLC | $1012786 | 298757 | 9.54% | 股份 |
| BRAIDWELL LP | $531857 | 156890 | 5.01% | 股份 |
| TYNDALL CAPITAL PARTNERS L P | $451594 | 155187 | 4.25% | 股份 |
| CITADEL ADVISORS LLC | $202705 | 59795 | 1.91% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $150759 | 44460 | 1.42% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $104802 | 30915 | 0.99% | 股份 |
| Rangeley Capital, LLC | $82411 | 24310 | 0.78% | 股份 |
| BlackRock, Inc. | $56942 | 16797 | 0.54% | 股份 |
| TWO SIGMA ADVISERS, LP | $35941 | 28300 | 0.34% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $31680 | 9345 | 0.30% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $24927 | 7353 | 0.23% | 股份 |
| VANGUARD GROUP INC | $20494 | 16137 | 0.19% | 股份 |
| Tower Research Capital LLC (TRC) | $6268 | 1849 | 0.06% | 股份 |
| UBS Group AG | $1939 | 572 | 0.02% | 股份 |
| GROUP ONE TRADING LLC | $651 | 192 | 0.01% | 股份 |
| OSAIC HOLDINGS, INC. | $440 | 130 | 0.00% | 股份 |
| Activest Wealth Management | $339 | 100 | 0.00% | 股份 |
| BARCLAYS PLC | $295 | 87 | 0.00% | 股份 |
| WHI TRUST Co LLC | $244 | 72 | 0.00% | 股份 |
| HRT FINANCIAL LP | $74 | 22054 | 0.00% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $14 | 4 | 0.00% | 股份 |
公司内部人士 21 位内幕人士 · 7 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Regina Margaret Graul | President and Chief Executive Officer | 2026年8月14日 M | 107523 | 0 | 0 | $0 |
| Rhonda M. Chicko | Chief Financial Officer | 2026年8月14日 M | 25018 | 0 | 0 | $0 |
| Anjeza Gjino | Chief Financial Officer | 2022年1月20日 A | 31599 | 0 | 0 | $0 |
| Mark G Currie | President and CSO | 2020年12月28日 S | 251648 | 0 | 0 | $0 |
| Cheryl Gault | Chief Operating Officer | 2022年1月20日 A | — | 0 | 0 | $0 |
| Andreas Busch | Chief Scientific Officer | 2022年1月20日 A | 254704 | 0 | 0 | $0 |
| Christopher I Wright | Chief Medical Officer | 2021年2月25日 S | 42728 | 0 | 0 | $0 |
| Peter M. Hecht | 董事 | 2026年7月16日 C | 910240 | 0 | 0 | $0 |
| Michael J Higgins | 董事 | 2025年3月25日 A | 30740 | 0 | 0 | $0 |
| Steven Hyman | 董事 | 2023年11月30日 A | 20000 | 0 | 0 | $0 |
| Errol B Desouza | 董事 | 2023年11月30日 A | 30000 | 0 | 0 | $0 |
| Terrance McGuire | 董事 | 2023年11月30日 A | 5552 | 0 | 0 | $0 |
| Stephanie Lovell | 董事 | 2022年6月14日 A | 2421 | 0 | 0 | $0 |
| Ole Isacson | 董事 | 2022年6月14日 A | 2421 | 0 | 0 | $0 |
| Michael Mendelsohn | 董事 | 2022年6月14日 A | 2421 | 0 | 0 | $0 |
| Marsha Fanucci | 董事 | 2022年6月14日 A | 16950 | 0 | 0 | $0 |
| George N Conrades | 董事 | 2022年6月14日 A | 4334 | 0 | 0 | $0 |
| Kevin Churchwell | 董事 | 2021年6月24日 A | 2421 | 0 | 0 | $0 |
| Amy Schulman | 董事 | 2020年6月16日 A | 21635 | 0 | 0 | $0 |
| IRONWOOD PHARMACEUTICALS INC | 10% 所有者 | 2019年4月1日 J | 0 | 0 | 0 | $0 |
| William Huyett | — | 2020年11月6日 S | 67590 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Peter M. Hecht ×9 申报 | 2026年7月20日 | 19.40% | 修订 | — | SEC |
| SLATE PATH MASTER FUND LP, SLATE PATH CAPITAL LP, JADES GP, LLC, DAVID GREENSPAN | 2022年10月21日 | — | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 2 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。